SK282953B6 - Hydroxylamínové deriváty a spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

Hydroxylamínové deriváty a spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK282953B6
SK282953B6 SK1713-97A SK171397A SK282953B6 SK 282953 B6 SK282953 B6 SK 282953B6 SK 171397 A SK171397 A SK 171397A SK 282953 B6 SK282953 B6 SK 282953B6
Authority
SK
Slovakia
Prior art keywords
formula
compound
alkyl
defined above
piperidine
Prior art date
Application number
SK1713-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK171397A3 (en
Inventor
L�Szl� �R�Gdi
Ede M�Rv�Nyos
Mih�Ly Barab�S
L�Szl� Jaszlits
Katalin B�R�
Andrea Jedn�Kovits
Heged�S Erzs�Bet Radv�Nyn�
M�Ria K�Rthy
Nagy Istv�Nn� Udvardy
Original Assignee
Biorex Kutat� �S Fejleszt� Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutat� �S Fejleszt� Rt. filed Critical Biorex Kutat� �S Fejleszt� Rt.
Publication of SK171397A3 publication Critical patent/SK171397A3/sk
Publication of SK282953B6 publication Critical patent/SK282953B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
SK1713-97A 1995-06-15 1996-06-14 Hydroxylamínové deriváty a spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie SK282953B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9501756A HU218480B (hu) 1995-06-15 1995-06-15 Hidroxilaminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
PCT/HU1996/000033 WO1997000251A1 (en) 1995-06-15 1996-06-14 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
SK171397A3 SK171397A3 (en) 1998-06-03
SK282953B6 true SK282953B6 (sk) 2003-01-09

Family

ID=10986948

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1713-97A SK282953B6 (sk) 1995-06-15 1996-06-14 Hydroxylamínové deriváty a spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (23)

Country Link
US (1) US6002002A (ko)
EP (1) EP0832079B1 (ko)
JP (1) JP4083800B2 (ko)
KR (1) KR100444780B1 (ko)
AT (1) ATE215075T1 (ko)
AU (1) AU703163B2 (ko)
BR (1) BR9608929A (ko)
CA (1) CA2221689C (ko)
CZ (1) CZ295547B6 (ko)
DE (1) DE69620175T2 (ko)
DK (1) DK0832079T3 (ko)
ES (1) ES2174077T3 (ko)
HR (1) HRP960279B1 (ko)
HU (1) HU218480B (ko)
IL (1) IL122141A (ko)
IN (1) IN185781B (ko)
PL (1) PL185592B1 (ko)
PT (1) PT832079E (ko)
SI (1) SI0832079T1 (ko)
SK (1) SK282953B6 (ko)
WO (1) WO1997000251A1 (ko)
YU (1) YU49419B (ko)
ZA (1) ZA964978B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA64716C2 (en) * 1996-08-09 2004-03-15 Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
WO2003057664A1 (en) 2002-01-11 2003-07-17 Biorex Kutató És Fejlesztö Rt. Carboxamidine derivatives and their use in the treatment of vascular diseases
WO2005074594A2 (en) 2004-01-30 2005-08-18 Great Lakes Chemical Corporation Production processes and systems, compositions, surfactants, monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams, and foam stabilizers
US8318656B2 (en) 2007-07-03 2012-11-27 E. I. Du Pont De Nemours And Company Production processes and systems, compositions, surfactants, monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams, and foam stabilizers
KR101405103B1 (ko) * 2014-03-25 2014-06-10 재 남 우 레버식 수동개방기구를 구비하는 초고압 압축가스 개폐장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE369944C (de) * 1918-03-07 1923-02-24 Anilin Fabrikation Ag Verfahren zur Darstellung von Tetrahydronaphthalin
DE2651083A1 (de) * 1976-11-09 1978-05-18 Hoechst Ag Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
EP0369944A1 (de) * 1988-11-18 1990-05-23 Ciba-Geigy Ag Substituierte Oxadiaminobutane
EP0495750A3 (en) * 1991-01-14 1992-09-16 Ciba-Geigy Ag Heterocyclic hydroxylamine

Also Published As

Publication number Publication date
DK0832079T3 (da) 2002-06-03
US6002002A (en) 1999-12-14
KR100444780B1 (ko) 2004-11-26
IN185781B (ko) 2001-04-28
ZA964978B (en) 1997-02-24
CZ401597A3 (cs) 1998-04-15
CA2221689A1 (en) 1997-01-03
BR9608929A (pt) 1999-06-15
HU9501756D0 (en) 1995-08-28
HRP960279A2 (en) 1997-12-31
WO1997000251A1 (en) 1997-01-03
SI0832079T1 (en) 2002-08-31
CA2221689C (en) 2007-08-07
PL324197A1 (en) 1998-05-11
CZ295547B6 (cs) 2005-08-17
MX9710172A (es) 1998-07-31
AU6237696A (en) 1997-01-15
ES2174077T3 (es) 2002-11-01
YU49419B (sh) 2006-01-16
EP0832079A1 (en) 1998-04-01
PL185592B1 (pl) 2003-06-30
AU703163B2 (en) 1999-03-18
KR19990022961A (ko) 1999-03-25
HUT74621A (en) 1997-01-28
IL122141A (en) 2003-07-06
IL122141A0 (en) 1998-04-05
PT832079E (pt) 2002-07-31
JP4083800B2 (ja) 2008-04-30
DE69620175T2 (de) 2002-08-22
JPH11507662A (ja) 1999-07-06
HU218480B (hu) 2000-09-28
YU36996A (sh) 1998-11-05
ATE215075T1 (de) 2002-04-15
HRP960279B1 (en) 2002-02-28
DE69620175D1 (de) 2002-05-02
SK171397A3 (en) 1998-06-03
EP0832079B1 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
EP1339717A1 (de) Neue carbamat-substituierte pyrazolopyridinderivate
HU211995B (en) Process to prepare novel benzoyl amino acid derivs. and pharmaceutical compns. contg.them
US5977130A (en) Intimal hypertrophy inhibitors
US4188391A (en) 4-[4-(Substituted)piperidino]quinazoline cardiac stimulants
PT97422A (pt) Metodo para a utilizacao de acidos hidroxamicos e n-hidroxi-ureias como anti-inflamatorios e metodo para a sua producao
BRPI0110184B1 (pt) derivado de piridina-1-óxido, e processo para a sua transformação em compostos farmaceuticamente eficazes
HU207843B (en) Process for producing diurea derivatives and pharmaceutical compositions containing them
SK282953B6 (sk) Hydroxylamínové deriváty a spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
US4210754A (en) Morpholino containing benzamides
HU207295B (en) Process for producing pyridine-2,4- and 2,5-dicarboxylic acid derivatives and pharmaceutical compositions containing them
US4243665A (en) 2-Heterocyclylalkyl-6-methoxy-naphthalenes
US4008265A (en) Novel bisphenoxy carboxylic acid derivatives and their salts
US3663610A (en) Amidine derivatives with spasmolytic,psychostimulant and anorexigenic properties
US4614824A (en) Novel apovincaminic acid derivatives
KR860000516B1 (ko) 페네틸피페리딘 화합물의 제조방법
MXPA97010172A (en) Derivatives of anti-ischemic hydroxylamine and pharmaceutical compositions
US4092324A (en) Diheterocyclic esters of 4-(1,1-bis-(phenoxy-propionic or -butoyric acid)-cyclohexane)α-methyl substituted
EP0438795A1 (de) Pyridin-2,4- und 2,5-dicarbonsäuredi(nitroxyalkyl) amide, Verfahren zu deren Herstellung sowie deren Verwendung
US4010161A (en) Piperazinoethyl-N-(2,3-dimethyl-5-oxo-1-phenyl-3Δ-pyrazolin-4-yl)carbamates
US3544579A (en) Substituted phenylcarbamic acid esters of cyclic amino alcohols
HU191938B (en) Process for production of new derivatives of 9 and 11 nitro-apovincamin acid
US2803627A (en) Therapeutic quinoline compounds
US5264452A (en) Benzofurancarboxamides and therapeutic agents
US4639449A (en) Morpholine containing propionylanilides and pharmaceutical compositions
DD247452A5 (de) Verfahren zur herstellung von n-phenyl-4-phenyl-1-piperazin-carboxamidin und verwandten verbindungen

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090614